Marwan Fakih, MD

Research Reports

KRAS/RAS Testing Is Associated With Reduced Risk of Treatment Discontinuation in Patients With Metastatic Colorectal Cancer

08/22/2018

Andrew J. Klink , PhD, MPH;

Bruce A. Bach , MD, PhD;

Urvi Mujumdar , MPH;

Bruce A. Feinberg , DO;

Alexandra Christodoulopoulou , MSc;

Marwan Fakih , MD;

Guy Hechmati , MD, MSc;

Abstract: Current clinical guidelines recommend that all patients with metastatic colorectal cancer (mCRC) have tumor tissue genotyped for RAS mutations. This study aimed to evaluate patient characteristics and...

...

08/22/2018

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Marwan Fakih, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products